News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
472,872 Results
Type
Article (18411)
Company Profile (34)
Press Release (454427)
Multimedia
Podcasts (21)
Webinars (10)
Section
Business (155201)
Career Advice (1314)
Deals (26419)
Drug Delivery (29)
Drug Development (48376)
Employer Resources (100)
FDA (9791)
Job Trends (10263)
News (242615)
Policy (17143)
Tag
Academia (1792)
Academic (2)
Accelerated approval (3)
Adcomms (4)
Allergies (37)
Alliances (34695)
ALS (39)
Alzheimer's disease (840)
Antibody-drug conjugate (ADC) (59)
Approvals (9839)
Artificial intelligence (168)
Autoimmune disease (15)
Automation (11)
Bankruptcy (248)
Best Places to Work (8166)
BIOSECURE Act (12)
Biosimilars (57)
Biotechnology (26)
Bladder cancer (52)
Brain cancer (14)
Breast cancer (171)
Cancer (1368)
Cardiovascular disease (84)
Career advice (1148)
Career pathing (20)
CAR-T (63)
Cell therapy (203)
Cervical cancer (15)
Clinical research (39860)
Collaboration (534)
Compensation (242)
Complete response letters (8)
COVID-19 (1129)
CRISPR (21)
C-suite (199)
Cystic fibrosis (64)
Data (1352)
Decentralized trials (1)
Denatured (6)
Depression (21)
Diabetes (140)
Diagnostics (4195)
Digital health (12)
Diversity (5)
Diversity, equity & inclusion (25)
Drug discovery (60)
Drug pricing (33)
Drug shortages (10)
Duchenne muscular dystrophy (54)
Earnings (65490)
Editorial (19)
Employer branding (14)
Employer resources (89)
Events (69701)
Executive appointments (660)
FDA (10537)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (3)
Frontotemporal dementia (5)
Funding (490)
Gene editing (60)
Generative AI (10)
Gene therapy (151)
GLP-1 (289)
Government (1491)
Grass and pollen (3)
Guidances (68)
Healthcare (11732)
Huntington's disease (7)
IgA nephropathy (21)
Immunology and inflammation (43)
Indications (17)
Infectious disease (1208)
Inflammatory bowel disease (84)
Inflation Reduction Act (4)
Influenza (32)
Intellectual property (62)
Interviews (201)
IPO (11610)
IRA (16)
Job creations (2393)
Job search strategy (1000)
Kidney cancer (6)
Labor market (20)
Layoffs (269)
Leadership (12)
Legal (4124)
Liver cancer (43)
Lung cancer (171)
Lymphoma (85)
Machine learning (2)
Management (39)
Manufacturing (201)
MASH (43)
Medical device (9067)
Medtech (9069)
Mergers & acquisitions (15238)
Metabolic disorders (325)
Multiple sclerosis (57)
NASH (7)
Neurodegenerative disease (41)
Neuropsychiatric disorders (12)
Neuroscience (1120)
NextGen: Class of 2025 (4149)
Non-profit (2439)
Now hiring (12)
Obesity (143)
Opinion (106)
Ovarian cancer (50)
Pain (47)
Pancreatic cancer (57)
Parkinson's disease (76)
Partnered (10)
Patents (132)
Patient recruitment (62)
Peanut (21)
People (48729)
Pharmaceutical (16)
Pharmacy benefit managers (10)
Phase I (12500)
Phase II (17161)
Phase III (13133)
Pipeline (958)
Policy (53)
Postmarket research (1523)
Preclinical (5440)
Press Release (49)
Prostate cancer (69)
Psychedelics (8)
Radiopharmaceuticals (157)
Rare diseases (204)
Real estate (4245)
Recruiting (37)
Regulatory (12530)
Reports (18)
Research institute (1491)
Resumes & cover letters (179)
Rett syndrome (4)
RNA editing (2)
RSV (20)
Schizophrenia (39)
Series A (80)
Series B (55)
Service/supplier (5)
Sickle cell disease (26)
Special edition (6)
Spinal muscular atrophy (75)
Sponsored (17)
Startups (2485)
Stomach cancer (5)
Supply chain (43)
Tariffs (18)
The Weekly (15)
Vaccines (308)
Venture capitalists (11)
Weight loss (65)
Women's health (19)
Worklife (12)
Date
Today (128)
Last 7 days (563)
Last 30 days (1793)
Last 365 days (20850)
2025 (7236)
2024 (22444)
2023 (26990)
2022 (35648)
2021 (38802)
2020 (37508)
2019 (31268)
2018 (23845)
2017 (21290)
2016 (21111)
2015 (24487)
2014 (18021)
2013 (14306)
2012 (19852)
2011 (19749)
2010 (20246)
Location
Africa (450)
Alabama (30)
Alaska (5)
Arizona (173)
Arkansas (10)
Asia (25329)
Australia (3614)
California (4107)
Canada (1382)
China (280)
Colorado (176)
Connecticut (207)
Delaware (124)
Europe (58435)
Florida (556)
Georgia (128)
Idaho (42)
Illinois (370)
India (18)
Indiana (188)
Iowa (7)
Japan (126)
Kansas (78)
Kentucky (4)
Louisiana (6)
Maine (54)
Maryland (452)
Massachusetts (3031)
Michigan (170)
Minnesota (235)
Mississippi (2)
Missouri (41)
Montana (11)
Nebraska (19)
Nevada (34)
New Hampshire (58)
New Jersey (1151)
New Mexico (8)
New York (1248)
North Carolina (630)
North Dakota (8)
Northern California (1761)
Ohio (123)
Oklahoma (9)
Oregon (25)
Pennsylvania (778)
Puerto Rico (12)
Rhode Island (21)
South America (743)
South Carolina (13)
Southern California (1603)
Tennessee (89)
Texas (558)
United States (15201)
Utah (85)
Virginia (73)
Washington D.C. (41)
Washington State (431)
West Virginia (3)
Wisconsin (46)
472,872 Results for "harvard business school".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Esteemed Harvard Medical School Professor Dr. Michael Gibson Appointed Chief Medical Advisor at Lexaria Bioscience
December 17, 2024
·
5 min read
Business
Healis Therapeutics announces collaboration with Massachusetts General Hospital (MGH) and affiliates of Harvard Medical School to advance clinical-stage neuroscience research
Healis Therapeutics is pleased to announce that it has entered a clinical collaboration with Massachusetts General Hospital (MGH), a founding member of the Mass General Brigham health system, and affiliates of Harvard Medical School (HMS).
March 26, 2024
·
1 min read
Press Releases
Harvard Bioscience Announces CFO Transition
April 11, 2025
·
3 min read
Press Releases
Roche announces launch of Roche Genentech Innovation Center Boston based at Harvard’s Enterprise Research Campus in Allston
March 7, 2025
·
6 min read
Press Releases
Vizgen Announces End of Litigation with 10x Genomics and Harvard University
April 3, 2025
·
2 min read
Press Releases
Harvard Bioscience Schedules First Quarter 2025 Earnings Conference Call for May 12, 2025 at 8:00 AM ET
May 5, 2025
·
1 min read
Business
Harvard Apparatus Regenerative Technology Reports First Quarter 2024 Financial Results and Recent Business Highlights
Harvard Apparatus Regenerative Technology, Inc. (OTCQB: HRGN) (“Harvard Apparatus Regenerative Technology” or the “Company”), a clinical-stage biotechnology company developing the technology to regenerate organs inside the body to treat severe diseases, today reported first quarter 2024 financial results.
May 13, 2024
·
6 min read
Genetown
Momentum Biotechnologies Welcomes Harvard Medical School Professor Dr. Ying Lu to its Scientific Advisory Board
Momentum Biotechnologies, a leading contract research organization specializing in mass spectrometry-based native detection technologies, is pleased to announce the appointment of Harvard Medical School Professor Dr. Ying Lu to its Scientific Advisory Board.
August 10, 2023
·
2 min read
Press Releases
Harvard Bioscience, Inc. to Participate in Two Investor Conferences in March 2025
March 13, 2025
·
1 min read
Business
Harvard Apparatus Regenerative Technology Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights
Harvard Apparatus Regenerative Technology, Inc. (OTCQB: HRGN) (“Harvard Apparatus Regenerative Technology” or the “Company”), a clinical-stage biotechnology company developing the technology to regenerate organs inside the body to treat severe diseases, today reported fourth quarter and full year 2023 financial results.
April 2, 2024
·
9 min read
1 of 47,288
Next
